December 9, 2025

Amphastar Pharmaceuticals (AMPH) Stock Analysis: Uncovering a 21.93% Potential Upside

Investors eyeing the healthcare sector should pay close attention to Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a dynamic player in the specialty and generic drug manufacturing industry. Despite recent market volatility,..

agilon health, inc. (AGL) Stock Analysis: Navigating a 39% Potential Upside in Healthcare

agilon health, inc. (AGL) represents an intriguing prospect within the healthcare sector, specifically in the medical care facilities industry. Headquartered in Westerville, Ohio, the company focuses on providing healthcare services..

Azenta, Inc. (AZTA) Stock Analysis: Unveiling a 13.65% Potential Upside Amidst Steady Growth

Azenta, Inc. (NASDAQ: AZTA), a key player in the healthcare sector’s medical instruments and supplies industry, has caught the eye of investors with its potential upside of 13.65%. With a..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: Evaluating the 121.70% Revenue Growth in the Booming Biotech Market

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) stands out in the biotechnology sector with its remarkable revenue growth and innovative approach to dermatological treatments. Headquartered in Westlake Village, California, this promising biopharmaceutical..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Healthcare Innovator with 33.7% Revenue Growth

Establishment Labs Holdings Inc (NASDAQ: ESTA), a prominent player in the healthcare sector specializing in medical devices, has been capturing attention with its impressive revenue growth and innovative product offerings...

Structure Therapeutics Inc. (GPCR) Stock Analysis: A Closer Look at Its 6.51% Potential Upside

Structure Therapeutics Inc. (NASDAQ: GPCR), a promising player in the biotechnology sector, has captured significant attention with its robust pipeline of novel oral small molecule therapeutics aimed at addressing chronic..

Clover Health Investments (CLOV): A 26% Upside Potential in the Healthcare Plans Sector

Clover Health Investments, Corp. (NASDAQ: CLOV) is making waves in the healthcare plans sector with its innovative approach to Medicare Advantage plans. With a market capitalization of $1.32 billion, Clover..

Omnicell, Inc. (OMCL): Investor Outlook Reveals Promising Upside Potential of 8.69%

Omnicell, Inc. (NASDAQ: OMCL), a prominent player in the healthcare sector, is gaining traction among investors, bolstered by its robust performance metrics and growth potential. Specializing in health information services,..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Eyeing Growth with a Promising 146.70% Revenue Surge

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a burgeoning name in the biotechnology sector, has been capturing investor attention with its impressive revenue growth and strategic focus on innovative therapeutic solutions, particularly..

Harrow, Inc. (HROW) Stock Analysis: Eyeing a 48.78% Potential Upside in the Competitive Ophthalmic Market

Investors looking for opportunities in the healthcare sector might find Harrow, Inc. (NASDAQ: HROW) an intriguing prospect, especially given its notable position in the ophthalmic pharmaceutical market. With a market..

AtriCure, Inc. (ATRC) Stock Analysis: Strong Buy Ratings and a 32.68% Potential Upside

Investors keeping an eye on the healthcare sector may find AtriCure, Inc. (NASDAQ: ATRC) an intriguing prospect. Known for its innovative medical instruments and supplies, AtriCure is a leader in..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 21.68% Potential Upside in the Healthcare Sector

Pacira BioSciences, Inc. (NASDAQ: PCRX) stands at a pivotal juncture in the healthcare sector, offering investors a potential upside of 21.68% based on current analyst ratings. With a market capitalization..

NeoGenomics, Inc. (NEO) Stock Analysis: Exploring a 14.75% Potential Upside in the Diagnostics Sector

Investors eyeing the healthcare sector’s diagnostics and research industry may find NeoGenomics, Inc. (NASDAQ: NEO) an intriguing prospect. With a notable potential upside of 14.75%, there’s reason to delve deeper..

Viridian Therapeutics, Inc. (VRDN): Investor Outlook with a Promising 24.88% Potential Upside

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company headquartered in Waltham, Massachusetts, is capturing investor attention with a striking 24.88% potential upside based on current analyst ratings. Specializing in discovering..

Certara, Inc. (CERT)

⚠️ No article content returned.

..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Biotechnology Innovator with a 29.59% Upside Potential

Wave Life Sciences Ltd. (NASDAQ: WVE), a Singapore-based biotechnology company, has captured the attention of investors with its innovative approach to RNA medicine development. As the company navigates the clinical-stage..

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Exploring a 31.40% Potential Upside

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX), a pioneering entity in the biotechnology sector, is making waves with its innovative approach to drug discovery and development. Positioned at the intersection of biology,..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: A 39.98% Potential Upside Amid Promising Clinical Pipeline

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is capturing the attention of the healthcare investment community with its robust focus on precision medicine in oncology. As a biotechnology firm dedicated to developing..

Biohaven Ltd. (BHVN) Stock Analysis: Exploring an 85.6% Potential Upside and Robust Clinical Pipeline

Biohaven Ltd. (NASDAQ: BHVN), a burgeoning player in the biotechnology sector, is actively capturing the attention of investors with its ambitious clinical pipeline and considerable potential upside. Currently priced at..

The Pennant Group, Inc. (PNTG) Stock Analysis: Exploring a 20% Upside Potential Amid Robust Revenue Growth

Investors eyeing opportunities in the healthcare sector may find The Pennant Group, Inc. (NASDAQ: PNTG) a compelling proposition. With a market cap nearing $1 billion, this Eagle, Idaho-based company operates..

Search

Funds

December 9, 2025

Search

Funds

December 9, 2025

FTSE 100

Funds